Find Academic Supervisors

John AitchisonView profile

Adjunct Professor

• Systems Biology
• Cell Biology
• Systems Cell Biology
• +7 more

John Aitchison is an Adjunct Professor affiliated with the Institute for Systems Biology and the Center for Infectious Disease Research in Seattle, Washington. He holds a Ph.D. from McMaster University and leads a research program in systems cell biology, focusing on the integration of molecular, genomic, and computational approaches to understand cellular complexity. Adjunct Professor, Institute for Systems Biology, Seattle Ph.D., McMaster University Dr. Aitchison’s research centers on systems cell biology, with key interests in nucleocytoplasmic transport, peroxisome biogenesis, and host-pathogen interactions. His lab employs functional genomics, proteomics, and computational modeling to dissect the molecular mechanisms underlying cellular organization and responses to environmental stimuli. He collaborates extensively with the Rachubinski and Wozniak laboratories at the University of Alberta. His recent publications reflect a strong focus on systems-level analyses of cellular processes, including gene regulation, chromatin dynamics, and immune responses to infection. Trends in his work include the development of integrative models to predict cellular behavior and the study of organelle dynamics in health and disease. CIHR Scholar AHFMR Scholar Dr. Aitchison has mentored numerous postdoctoral fellows and research scientists, including Fred Mast, Song Li, and Thurston Herricks. His lab has received support from various funding agencies, enabling large-scale proteomic and genomic studies. He also contributes to scientific discourse through editorial roles, as seen in his commentary on MBoC. His laboratory operates at the intersection of experimental and computational biology, developing and applying high-throughput technologies to address fundamental questions in cell biology and infectious disease.

Todd VanderahView profile

Academic

• Cancer Pharmacology
• Neuroscience
• Pain Research
• +4 more

Todd Vanderah is a Regents Professor at the University of Arizona , affiliated with multiple departments including Pharmacology , Anesthesiology , Neurology , and Neuroscience . He serves as Co-Director of the MD/PhD Dual Degree Program , Department Head of Pharmacology , and Director of the Comprehensive Pain and Addiction Center . His research focuses on pain mechanisms, opioid tolerance, endogenous opioid systems, and neuroinflammatory pathways. Leadership Roles : Pharmacology Executive Committee, Dean's Council on Faculty Affairs, Director of Medical Pharmacology Graduate Program Key Research Areas : Chronic pain, cannabinoid-opioid synergy, blood-brain barrier integrity, neuroimmune signaling Recent publications highlight his work on opioid-cannabinoid interactions , sphingosine-1-phosphate pathways , and novel pain models (e.g., red light exposure, DAGLα inhibition). His studies frequently employ rodent models to explore pharmacological interventions for neuropathic pain, traumatic brain injury, and opioid-induced dysregulation. Findings from Vanderah's lab have advanced understanding of CRMP2 phosphorylation , NHE1 regulation , and neuroinflammatory mediators in pain states. Collaborations span pharmacology , neuroscience , and oncology , with implications for drug discovery and clinical pain management.

Massimo GulisanoView profile

Professor

• Applied Biology
• Developmental Biology
• Molecular Biology
• +20 more

Massimo Gulisano is a Full Professor of Applied Biology at the Department of Drug Sciences, University of Catania, Italy. He serves as Director of the Laboratory of Synthetic and Systems Biology (SynSysLab) and Founder and Director of the Research Centre for Molecular Preclinical and Translational Imaging – IMPRonTE. With a strong international research background, he has contributed significantly to developmental biology, molecular mechanisms in cell differentiation, and translational applications in neurobiology and oncology. His research interests span Applied Biology, Developmental Biology, Molecular Biology, Experimental Neurobiology, Experimental Oncology, Synthetic Biology, Systems Biology, Translational Medicine, and Biotechnology Innovation . His work integrates fundamental biological processes with clinical and industrial applications, particularly in cancer and neural development. He has extensive expertise in in vitro and in vivo models to study cell determination, migration, and differentiation. The analysis of his recent publications reveals a consistent focus on molecular and cellular mechanisms underlying development and disease, with strong emphasis on genomics, imaging, and translational models. His work appears in top-tier journals such as Nature, Science, PNAS, EMBO, and PLOS , reflecting broad interdisciplinary impact across biology, medicine, and biotechnology. Scientific Awards and Recognition: No specific awards mentioned in the text Advising and Grants: Massimo Gulisano has successfully raised over 20 million euros in research funding from national and international public and private sources over the past decade. While no formal students are listed, his leadership in multiple research centers and startups indicates a strong mentorship and team-building role. His industrial engagement includes advisory and entrepreneurial roles in health biotechnology and sustainable innovation. Labs and Teams: He leads the SynSysLab (Synthetic and Systems Biology Laboratory) and founded the IMPRonTE research center focused on molecular preclinical and translational imaging. These entities drive interdisciplinary research at the interface of basic science and clinical applications.

Alexander GottschalkView profile

Professor

• Optogenetics
• Synaptic Transmission
• Ion Channels
• +7 more

Dr. Alexander Gottschalk is a Professor in the Department of Radiation Oncology at the University of California San Francisco (UCSF). He serves as Director of the CyberKnife Radiosurgery Program and Vice Chair of Clinical Services, overseeing clinical operations at multiple UCSF sites including Mount Zion, Parnassus Mission Bay, and Washington Hospital. He actively participates in clinical care for Urologic, Thoracic, Orthopedic, and Gastrointestinal Oncology programs, while also mentoring radiation oncology residents and medical students. MD, University of Chicago (1996) Dr. Gottschalk's research spans both neuroscience (focusing on optogenetics, synaptic transmission, and C. elegans models) and radiation oncology (specializing in stereotactic body radiotherapy, brachytherapy, and cancer treatment optimization). His recent publications highlight innovations in light-activated ion channels, optogenetic tools for neuronal control, and advanced radiation therapy frameworks. Notable clinical research includes trials on prostate cancer treatment combining radiation therapy with pharmacological agents, and systematic analyses of radiation therapy for adrenal metastases. His work also encompasses neurogenetic engineering and biomedical imaging applications. Commitment to Patient Care Award, UCSF (2012-2013) Lifetime Teaching Award, UCSF (2012-2013) Educator of the Year, UCSF (2009-2010) As Vice Chair, Dr. Gottschalk oversees clinical operations and proctors faculty in CyberKnife Radiosurgery. He collaborates extensively with multidisciplinary teams across oncology programs and contributes to the development of optogenetic technologies through his laboratory research.

• Cell and Molecular Biology
• Endocrinology and Diabetes
• Pediatrics
• +7 more

Svetlana Lajic is an Adjunct Professor in Pediatric Endocrinology and Inherited Metabolic Diseases at the Department of Women's and Children's Health, Karolinska Institutet , and a Senior Consultant at Karolinska University Hospital, Stockholm, Sweden. She serves as the European Pediatric Chair for the adrenal thematic group in Endo ERN and contributes to the Swedish Pediatric Association as Treasurer. Her research focuses on cognitive functioning and brain development in individuals with rare endocrine disorders, including Congenital Adrenal Hyperplasia (CAH) and Addison's Disease , investigating the long-term effects of prenatal dexamethasone treatment and epigenetic alterations . She leads studies on metabolic outcomes, neural connectivity, and quality of life in patients with inborn errors of metabolism (IEM). Key Research Areas: Cognitive and brain development in CAH and Addison's Prenatal dexamethasone treatment safety Epigenetic effects of glucocorticoid exposure Neonatal screening for IEM Clinical Roles: Senior Consultant, Pediatric Endocrinology European Pediatric Chair, Endo ERN adrenal group

• Epidemiology
• Public Health
• Work Disability
• +4 more

Pia Svedberg is an Associate Professor and Principal Researcher at Karolinska Institutet's Department of Clinical Neuroscience, Division of Insurance Medicine. Her research focuses on understanding genetic and environmental determinants of work disability, particularly sickness absence and disability pensions, through twin cohort studies and national register data. PhD in Epidemiology (2006), Karolinska Institutet Docent in Epidemiology (2013), Karolinska Institutet BSc in Psychology (1995), Uppsala University Her research group examines musculoskeletal and mental disorders' impact on labor market participation, utilizing Swedish Twin Registry data and national health registers. Key projects include the Swedish Twin project Of Disability pension and Sickness absence (STODS) and Sustainable working life: early determinants and later predictors (SustWork) , analyzing comorbidity, genetic liability, and workplace environment factors. Recent publications highlight her work on twin trajectories of work disability, gender-specific risk factors, and the interplay between mental health and occupational outcomes. Collaborations span Nordic institutions like University of Helsinki, University of Southern Denmark, and Norwegian Institute of Public Health through the NorTwinDiSa network. She leads studies investigating how early life events, health behaviors, and psychosocial factors influence sustainable working life, emphasizing methodological rigor through co-twin control designs and longitudinal analysis.

Marcus GrimmView profile

Professor

• Alzheimer's Disease Research
• Lipid Metabolism
• Nutritional Therapy
• +5 more

Professor Marcus Grimm serves as Academic Head of Centre of Research and Funding and Professor and Programme Director for the Bachelor's Programme in Nutritional Therapy and Counselling at the Cologne Campus of SRH University of Health since October 1, 2021. With a distinguished career spanning over two decades in Alzheimer's disease research, Prof. Grimm has established himself as a leading expert in the intersection of lipid metabolism and neurodegenerative disorders. Prof. Grimm completed his biochemistry studies at the Johann Wolfgang Goethe University in Frankfurt with support from the German Academic Scholarship Foundation. He earned his PhD summa cum laude from the Center for Molecular Biology (ZMBH) at Heidelberg University, where he demonstrated the bidirectional interaction between Alzheimer's disease and lipid homeostasis, publishing findings in high-impact journals including Nature Cell Biology. During his doctoral studies, he concurrently completed an MBA through distance learning. He later habilitated at Saarland University in the field of Alzheimer's disease prevention, receiving a research prize in 2010. Prof. Grimm's research program has consistently focused on understanding the molecular mechanisms linking lipid metabolism to Alzheimer's disease pathogenesis. His work has established critical connections between dietary components, lipid homeostasis, and amyloid-beta processing. With an h-index of 36 and over 3,500 total citations, his research has significantly advanced understanding of how nutritional interventions might prevent or mitigate Alzheimer's disease progression. Key areas of investigation include fatty acid metabolism, vitamin effects on neurodegeneration, and lipidomics approaches to understanding Alzheimer's disease mechanisms. His most recent publications demonstrate a continued focus on lipidomics, fatty acid metabolism, and nutritional interventions in Alzheimer's disease. The research shows promising connections between specific dietary components and amyloid-beta degradation pathways, with potential implications for therapeutic development. His work on the LipiDiDiet clinical trial represents a significant contribution to understanding how multinutrient formulations might affect cognitive decline in prodromal Alzheimer's disease. Research prize in 2010 Summa cum laude for PhD Multiple patents related to Alzheimer's disease treatment Extensive publication record with over 3500 citations Beyond his research and teaching responsibilities, Prof. Grimm provides advisory services in nutritional counseling and therapy and is involved in establishing a nutritional counseling center. He maintains an active research laboratory that operates as part of the German Institute for Dementia Prevention, providing opportunities for student involvement and continuing his groundbreaking work at the intersection of nutrition and neurodegenerative disease.

Matthew GillView profile

Associate Professor

• Aging
• Genetics of Aging
• Insulin Signaling
• +5 more

Matthew Gill is an Associate Professor in the Department of Genetics, Cell Biology and Development within the College of Biological Sciences at the University of Minnesota, Twin Cities. He leads the Gill Lab as part of the Masonic Institute on the Biology of Aging and Metabolism and the Medical Discovery Team on Aging, focusing on translational aging research since their 2017 founding. Dr. Gill's research employs C. elegans to dissect fundamental aging mechanisms through genetic, chemical, and biochemical approaches. His lab discovered a novel alternatively spliced insulin receptor (DAF-2B) that acts as a decoy to sequester insulin ligands and modulate aging, alongside identifying an endocannabinoid signaling system in nematodes. Current work investigates DAF-2B's splicing regulation and mammalian conservation, bridging developmental processes like dauer formation with lifespan extension pathways. Analysis of his publication record (2014-2023) reveals consistent focus on insulin signaling dynamics, alternative splicing events, and lipid-based neuromodulation in aging. His work demonstrates how conserved pathways—particularly insulin/IGF-1 signaling and stress responses—can be targeted to influence longevity, with implications for age-related metabolic disorders and neurodegenerative conditions. Scientific Awards: No specific awards were mentioned in the provided sources. Dr. Gill advises PhD students including Tom Hodder (co-advised with Chad Myers), who develops geroprotector screening methods, and mentors postdoctoral researchers like Bryan Martinez studying DAF-2B regulation. His research is institutionally supported through the Masonic Institute and Medical Discovery Team on Aging, indicating sustained funding for mechanistic aging studies. Current grants focus on insulin receptor splicing mechanisms and cross-species conservation of aging pathways. The Gill Lab operates from Nils Hasselmo Hall, leveraging C. elegans genetics to explore therapeutic targets for human aging. Ongoing projects examine how environmental stressors interact with genetic factors to influence aging, with future work directed toward mammalian validation of decoy receptor mechanisms and drug discovery for age-related decline.

Robert T. DirksenView profile

Professor

• Intracellular Calcium Signaling
• Muscular Dystrophy
• Ryanodine Receptor (RYR1) Pathophysiology
• +6 more

Robert T. Dirksen is a Professor in the Department of Pharmacology and Physiology at the University of Rochester School of Medicine and Dentistry. His research program bridges muscular dystrophies , cardiac disease , and calcium signaling pathophysiology , with specific focus on RYR1-related disorders , mitochondrial dysfunction , and store-operated calcium entry . He leads a multi-disciplinary lab using Dirksen Lab to investigate disease mechanisms and develop novel therapies. Education: Ph.D. in Pharmacology (University of Rochester, 1991) M.S. in Pharmacology (University of Rochester, 1988) B.S. in Biology (University of Notre Dame, 1985) Dr. Dirksen's work reveals how calcium dysregulation drives muscle degeneration through four major themes: excitation-contraction coupling , mitochondrial calcium uptake , store-operated entry systems , and molecular mechanisms of myotonic dystrophy . His 2025 Nature Aging study demonstrated inflammation-induced epigenetic erosion in aged stem cells, while 2024 EMBO Journal work developed ORAI1-based therapeutic models for tubular aggregate myopathy. Scientific Recognition: 2015: Department Chair 2012: Department Vice-Chair 2002: Graduate Student Society Faculty Mentoring Award His lab website highlights collaborations with C. Thornton (myotonic dystrophy), JP Jin (calcium channel regulation), and JJ Dowling (zebrafish models). Current projects include RYR1 disease modeling , SOCE mechanisms , and mitochondrial calcium dynamics in striated muscle.

Hye Yoon ParkView profile

Associate Professor

• Biomedical Technologies
• RNA Regulation
• Neuroscience
• +5 more

Dr. Hye Yoon Park is an Associate Professor in the Department of Electrical and Computer Engineering at the University of Minnesota. Her research focuses on developing advanced biomedical technologies for studying RNA regulation at the single-molecule and single-cell levels in living tissues and organisms. Research Interests Real-time imaging of gene expression dynamics Activity-dependent transcription in neural networks RNA localization and transport mechanisms Development of fluorescent RNA labeling systems Key Techniques Live-cell and in vivo imaging Genetic engineering of mouse models Quantitative single-molecule analysis Computational modeling of RNA transport Her recent publications highlight interdisciplinary approaches combining RNA biology, neuroscience, and nanotechnology, with particular emphasis on Arc and β-actin mRNA dynamics in neurons, optogenetic control of RNA condensation, and novel diagnostic tools like nanoparticle-enhanced QuIC assays for Parkinson's disease. She actively seeks graduate students for research and has developed specialized software such as HybTrack for particle tracking analysis.

Anthony Burgos-RoblesView profile

Assistant Professor

• Neuroscience
• Emotion
• Learning and Memory
• +7 more

Anthony Burgos-Robles is an Assistant Professor in the Department of Neuroscience, Developmental and Regenerative Biology at the University of Texas at San Antonio (UTSA), College of Sciences. His research focuses on the neural mechanisms of emotion, learning, memory, motivation, and stress, particularly involving cortical and amygdala circuits. He is actively engaged in neuroscience research with recent publications in top-tier journals such as Cell , eLife , and Translational Psychiatry . Research Interests: Cortical and amygdala circuits Emotion and fear processing Learning and memory, especially observational and safety learning Motivation and reward Effects of stress on neural and behavioral outcomes Prefrontal regulation of emotional behavior His recent work (2023–2024) explores how social threat alters brain connectivity, how reward contingencies modulate amygdala neurons, and how prefrontal regions regulate safety learning under ethologically relevant threats. These studies often integrate behavioral paradigms, in vivo recordings, and computational models. Scientific Awards: No awards explicitly mentioned in the provided text. Advising and Grants: While no current students or grant funding are explicitly listed, his active publication record and faculty position suggest ongoing mentorship and research funding. He collaborates with leading researchers such as Kay M. Tye, Gregory J. Quirk, and Anna Beyeler. Labs and Research Teams: Dr. Burgos-Robles leads a neuroscience research lab at UTSA focused on emotional circuitry. His work is part of broader collaborations within UTSA and with external institutions, particularly in the study of fear, motivation, and social behavior.

William HortonView profile

Academic

• Circadian Rhythms
• Drug Abuse
• Nicotine Addiction
• +7 more

William Horton is an Assistant Teaching Professor at the Biobehavioral Health Department within Penn State University's College of Health and Human Development . His research focuses on the intersection of circadian rhythms and substance abuse, particularly nicotine addiction, examining how molecular and genetic changes influence behavior and vice versa. Education Ph.D. in Integrative Physiology and Neuroscience from University of Colorado - Boulder B.S. in Zoology from Michigan State University Research Interests encompass: Molecular mechanisms linking circadian rhythms and addiction Genetic influences on drug-seeking behavior Neuroimaging of substance exposure effects Environmental factors (light, sleep) in maternal and child health Stress interactions with opioid and nicotine addiction Translational preclinical models of addiction and aging Selected Publications demonstrate expertise in neurogenetics, sleep disorders, and addiction science, with recent work on miRNA regulation in stress models (2024), opioid neuroimaging (2023), and cross-species transcriptomic studies (2019).

Licio CollavinView profile

Professor

• Molecular Oncology
• Cancer Biology
• Tumor Suppressor Genes
• +3 more

Licio Collavin is a Full Professor in Cellular and Applied Biology at the Department of Life Sciences, University of Trieste. He serves as a member of the Research Evaluation Commission (CVR), Department Board, and Course of Study Recommendations Committee. Additionally, he acts as Deputy Coordinator for multiple Doctoral Colleges in Molecular Biomedicine and Medical Biotechnology. Dr. Collavin's educational background includes: Graduated in Biological Sciences PhD from the International School for Advanced Studies (SISSA) in Trieste Postdoctoral research at Harvard Medical School in the Department of Cell Biology under Prof. Marc W. Kirschner Professor Collavin's research focuses on the molecular basis of cancer, particularly on tumor suppressor genes in differentiation and oncogenesis. His laboratory investigates the complex interaction of cancer cells with their environment, including other cells and the immune system. Key research areas include: Exploring gain-of-function properties of mutant p53 through novel interacting proteins Studying the tumor suppressor DAB2IP as a target for post-transcriptional inactivation in cancer Investigating how mutant p53 binds and inhibits DAB2IP, affecting cancer cell responses to inflammation and insulin Examining DAB2IP inactivation by micro-RNAs and their impact on cancer progression Analysis of Professor Collavin's recent publications reveals a consistent focus on molecular oncology, particularly the interplay between tumor suppressor genes and cancer progression. His work demonstrates a strong emphasis on p53 mutations and their oncogenic properties, DAB2IP function and inactivation mechanisms, and the complex signaling pathways that regulate cancer cell behavior. The research spans from fundamental molecular mechanisms to potential therapeutic applications, showing a translational approach to cancer biology. Professor Collavin leads an active research group with several doctoral students and postdoctoral fellows. His laboratory has received funding for multiple research projects including "BIO-D - Development of Diagnostic Biomarkers for Precision Medicine and Personalized Therapy," "National Center for Gene Therapy and Drug Based on RNA Technology," and "Innovative Models for Advanced Omics Science Applications." His group members include current researchers Olga Pastorino, Nicoletta Franco, Arooj Fatima, and Monica Rossin, as well as notable past members who have gone on to successful careers in academia and industry. Professor Collavin's laboratory is part of the Tumor Suppressor Genes in Differentiation and Oncogenesis research group within the Department of Life Sciences. The lab focuses on understanding the molecular mechanisms driving cancer progression and the complex interactions between cancer cells and their microenvironment. Current research projects include investigating mutant p53's impact on cancer cell responses to microenvironmental stress and exploring DAB2IP regulation in epithelial cells under conditions of high cell density.

Marta ShahbaziView profile

Research Fellow

• Developmental Biology
• Stem Cell Biology
• Embryogenesis
• +4 more

Dr. Marta Shahbazi is an Affiliated Principal Investigator at the Cambridge Stem Cell Institute, University of Cambridge, and maintains a primary affiliation with the MRC Laboratory of Molecular Biology. She leads the Shahbazi Lab, which focuses on understanding the mechanisms that control pluripotent stem cell identity and fate in physiological 3D contexts. Her research bridges developmental biology and stem cell research, with particular emphasis on how tissue architecture influences stem cell behavior during embryonic development and potential regenerative applications. Dr. Shahbazi's research interests center around pluripotent stem cells and their role in early mammalian development. Her work investigates how pluripotent cells undergo concomitant changes in shape and identity to establish the foundation of the body plan. She is particularly interested in epithelial tissue determinants and their contribution to stem cell fate decisions. Her lab employs novel methods to culture mouse and human embryos, 3D embryonic stem cell models, and adult tissue organoids to understand the molecular pathways coordinating tissue shape and stem cell fate during pluripotency exit and acquisition. Analysis of Dr. Shahbazi's recent publications reveals a strong focus on human and mouse embryogenesis, with particular attention to tissue morphogenesis, cell delamination, and the molecular mechanisms underlying pluripotency transitions. Her work spans from basic developmental mechanisms to potential applications in regenerative medicine, with increasing emphasis on human embryo models in recent years. The research demonstrates interdisciplinary approaches combining cell biology, developmental biology, and tissue engineering principles. Dr. Shahbazi has received recognition through multiple publications in high-impact journals including Nature, Developmental Cell, and Cell Stem Cell. Her work on human embryo development and stem cell-based embryo models has contributed significantly to the field. Dr. Shahbazi mentors several researchers in her lab, including Viviane de Souza Rosa, Miguel Ángel Ortiz Salazar, Rina Sakata, Nanami Satoh, Luca Schwarz, and Anfu Wang. Her research is supported by the Cambridge Stem Cell Institute and the MRC Laboratory of Molecular Biology, providing resources for advanced imaging, genomics, and tissue culture facilities. The Shahbazi Lab is part of the broader Cambridge research ecosystem focused on stem cells and developmental biology, collaborating with other principal investigators at the Cambridge Stem Cell Institute.

Nicolae MorarView profile

Associate Professor

• Applied Ethics
• Philosophy of Biology
• 20th Century Continental Philosophy
• +4 more

Nicolae Morar is an Associate Professor of Environmental Studies and Philosophy at the University of Oregon, holding joint appointments in both departments within the College of Arts and Sciences. He is also an Associate Member of the Institute of Ecology and Evolution. Currently on sabbatical leave for the 2024-2025 academic year, Morar has established himself as a significant voice at the intersection of philosophy, ethics, and biological sciences. His research interests span Applied Ethics, Philosophy of Biology, and 20th Century Continental Philosophy, with particular focus on microbiome ethics, human nature debates, and the ethical implications of biological research. Morar's work bridges traditional philosophical inquiry with contemporary scientific understanding, especially in how microbial communities challenge conventional notions of individuality and agency. Morar's scholarly output reveals a consistent trajectory exploring the boundaries between biological facts and ethical considerations. His recent publications demonstrate increasing engagement with microbiome research and its philosophical implications, moving beyond traditional bioethics to consider how microbial communities reshape our understanding of human nature and moral responsibility. His work on Foucault and Deleuze provides important continental philosophical context for contemporary bioethical debates. National Endowment for Humanities grant ($294,236) as Co-PI for 'The Seminars of Gilles Deleuze' translation project 2017 Interdisciplinary Environmental Studies Seed Grant ($3,000) as PI for 'Genes, Microbes, and Ourselves' Multiple grants from University of Oregon's College of Arts and Sciences American Society for Bioethics & Humanities Early Career Travel Grant Morar has been actively involved in teaching across both undergraduate and graduate levels, developing specialized courses in environmental ethics, clinical ethics, philosophy of biology, and continental philosophy. His teaching portfolio demonstrates a commitment to interdisciplinary approaches that connect philosophical inquiry with pressing environmental and biomedical issues. His work with institutions like PeaceHealth Hospitals indicates practical engagement with clinical ethics beyond the academy.